JPRN-jRCT1080223004已完成Unknown
Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) Prevention of Relapse of Multiple Sclerosis
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 1,332 人开始时间: 2015年11月4日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 1,332
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •All patients treated with Copaxone from the first day of market launch of the product
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A trial comparing continuous subcutaneous hydrocortisone therapy with pulsatile subcutaneous hydrocortisone therapy in patients with Addison`s diseaseEUCTR2013-004189-33-NOHaukeland University Hospital10
已完成
不适用
Subcutaneous injections of depot medroxyprogesterone acetate versus Leuprolide acetate for the reduction of pain associated with endometriosis in European and Asian women. A Phase III, randomized, parallel group, multinational, multicenter study including evaluations of bone mineral density and substudies of coagulation and lipid profiles.PER-025-01PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
尚未招募
Unknown
Pharmacist Driven Effective Use of Topical CorticosteroidsCTRI/2023/05/053287Sreeraj K
已完成
不适用
HEMLIBRA Subcutaneous injection Special Drug Use Surveillance (with Hemophilia A without Inhibitors).Hemophilia AJPRN-UMIN000037503Chugai Pharmaceutical Co. Ltd.87
已完成
不适用
Single Injection 17-hydroxyprogesterone caproate in Preterm labour: a randomised controlled trialISRCTN22145023niversity of Malaya Medical Centre (Malaysia)256